Literature DB >> 18759249

Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.

Junko Ishii1, Riko Kitazawa, Kiyoshi Mori, Kevin P McHugh, Eiichi Morii, Takeshi Kondo, Sohei Kitazawa.   

Abstract

Receptor activator of NF-kappaB (RANK) is a receptor for RANK ligand (RANKL), and signals transduced by RANK-RANKL interaction are prerequisite for the differentiation and activation of osteoclasts. We cloned and characterized a 6-kb fragment containing the 5'-flanking region of the mouse RANK gene. A fragment of 1-kb from the transcription start sites containing four Sp-1 sites and putative binding sites for MITF, CRE/AP-1, and PU.1 was ligated to the pGL3-basic vector, and the promoter activity was confirmed by transfection studies. By electrophoretic gel motility shift assay, both PU.1 and proximal MITF binding site showed specific DNA-protein binding. Co-transfection studies with MITF- and PU.1-expression vectors revealed that MITF and PU.1 increased RANK promoter activity three- and twofold, respectively, and sixfold synergistically. Taken together, these results show that RANK transcription is positively regulated by both PU.1 and MITF. The effect of lipopolysaccharide (LPS) on RANK gene expression, analyzed by in situ hybridization using mouse bone tissue, showed that LPS decreased RANK transcripts of both precursor and mature osteoclasts. Furthermore, LPS treatment of RAW.264.7 cells decreased their RANK mRNA expression by 70%, mirroring the decrease of PU.1 and MITF mRNA. Short-term treatment with LPS decreased the promoter activity of pGL3-WT by 70%. Although LPS has been reported to promote osteoclastogenesis in chronic and local pyogenic inflammation, we speculate that LPS per se may directly suppress RANK expression in the osteoclastic cell lineage by down-regulating the expression of PU.1 and MITF genes in acute and systemic severe endotoxemia, such as in septic shock. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759249     DOI: 10.1002/jcb.21886

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate.

Authors:  Mati Mann; Omer Barad; Reuven Agami; Benjamin Geiger; Eran Hornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-18       Impact factor: 11.205

2.  Identification and analysis of function of a novel splicing variant of mouse receptor activator of NF-κB.

Authors:  Satomi Mukai; Riko Kitazawa; Junko Ishii; Takeshi Kondo; Akihiro Hakozaki; Keisuke Horiuchi; Ryuma Haraguch; Kiyoshi Mori; Sohei Kitazawa
Journal:  Mol Cell Biochem       Date:  2010-12-14       Impact factor: 3.396

3.  Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta.

Authors:  Bitnara Lee; Tae-Hwan Kim; Jae-Bum Jun; Dae-Hyun Yoo; Jin-Hyun Woo; Sung Jae Choi; Young Ho Lee; Gwan Gyu Song; Jeongwon Sohn; Kyung-Hyun Park-Min; Lionel B Ivashkiv; Jong Dae Ji
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

4.  Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Authors:  Christopher A Lord; David Savitsky; Raquel Sitcheran; Kathryn Calame; Jo Rae Wright; Jenny Pan-Yun Ting; Kristi L Williams
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Discovering causal signaling pathways through gene-expression patterns.

Authors:  Jignesh R Parikh; Bertram Klinger; Yu Xia; Jarrod A Marto; Nils Blüthgen
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

6.  MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation.

Authors:  Michael S Valerio; Bethany A Herbert; Alfred C Griffin; Zhuang Wan; Elizabeth G Hill; Keith L Kirkwood
Journal:  Bone       Date:  2013-11-20       Impact factor: 4.398

7.  Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.

Authors:  Anastasios D Papanastasiou; Chaido Sirinian; Haralabos P Kalofonos
Journal:  Breast Cancer Res       Date:  2012-07-23       Impact factor: 6.466

8.  Inhibitory effect of saliva on osteoclastogenesis in vitro requires toll-like receptor 4 signaling.

Authors:  Heinz-Dieter Müller; Jordi Caballé-Serrano; Adrian Lussi; Reinhard Gruber
Journal:  Clin Oral Investig       Date:  2017-01-18       Impact factor: 3.573

9.  Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.

Authors:  Zhi-Feng Wei; Bei Tong; Yu-Feng Xia; Qian Lu; Gui-Xin Chou; Zheng-Tao Wang; Yue Dai
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

Review 10.  MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.

Authors:  Xiao Ji; Xiang Chen; Xijie Yu
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.